Dexcom will present the full data from several studies at the Advanced Technologies and Treatments for Diabetes conference, ...

Never miss an important update on your stock portfolio and cut through the noise. Over 7 million investors trust Simply Wall St to stay informed where it matters for FREE. DexCom (NasdaqGS:DXCM) is ...

Find winning stocks in any market cycle. Join 7 million investors using Simply Wall St's investing ideas for FREE. DexCom (NasdaqGS:DXCM) is seeing higher adoption of its continuous glucose monitoring ...

Researchers who use Fitabase to capture data from Fitbit and Garmin devices will soon be able to capture a new kind of data: continuous glucose monitoring data from Dexcom products. The ability to ...

DexCom's Q3 performance shows impressive organic growth rates and increased revenue guidance for 2023. The company's strategic focus on international markets and expanding customer bases indicates ...

DexCom, Inc. DXCM is well positioned for growth in the coming quarters, supported by the significant potential of the ...

The FDA has established a Digital Health Advisory Committee focused on addressing the complexities of digital health technologies, such as AI, augmented reality, and wearables. This committee aims to ...

DexCom, Inc. DXCM is well-poised for growth in the coming quarters, backed by its strong product portfolio. A robust first-quarter 2024 performance, along with a series of favorable coverage decisions ...

DexCom, Inc. is a medical device company, which engages in the design, development, and commercialization of glucose monitoring systems for ambulatory use by people with diabetes. Its products include ...